How AI is set to disrupt pharma IP business models

Increasing numbers of patent applications prove that AI is having a profound impact on the pharmaceutical industry. BenevolentAI’s Gareth Jones identifies numerous arguments for and against amending inventorship rules

Enter your details below to log into your account.

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.

Gareth Jones

Vice president of intellectual property | BenevolentAI

Twitter

28 Jul 2021

@IAM_Alerts Federal Circuit judge vacancies are like London buses, it seems. You wait ages for one then a few come along one af… https://t.co/uxjrJGOvqr Read more

28 Jul 2021

@IAM_Alerts South Africa awards world’s first AI-invented patent, but it may not be that big a deal https://t.co/fR2Y4H5700 https://t.co/Xj7QC5rgPi Read more

28 Jul 2021

@IAM_Alerts How do you get a patent where the inventor is an AI machine? Go to a country like South Africa that does not conduc… https://t.co/FS1PMMeSSK Read more

28 Jul 2021

@IAM_Alerts RT @patentbuddy: Isn’t South Africa a patent registration country? https://t.co/XVMSFAiUs2 Read more